1-2 of 2
Daniel A. DeAngelo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase IB Study of PKC412, an Oral FLT3 Kinase Inhibitor, in Sequential and Simultaneous Combinations with Daunorubicin and Cytarabine (DA) Induction and High-Dose Cytarabine Consolidation in Newly Diagnosed Adult Patients (pts) with Acute Myeloid Leukemia (AML) under Age 61.

Richard M. Stone, MD, Thomas Fischer, MD, Ronald Paquette, MD, Gary Schiller, MD, Charles A. Schiffer, MD, Gerhard Ehninger, MD, Jorge Cortes, MD, Hagop Kantarjian, MD, Daniel A. DeAngelo, MD, PhD, Georgio Massimini, MD, Xiaoming Li, PhD, Penny Phillips, PhD, Francis Giles, MD
Journal: Blood
Blood (2006) 108 (11): 157.
https://doi.org/10.1182/blood.V108.11.157.157
Published: 2006
Journal Articles

Phase IB Study of PKC412, an Oral FLT3 Kinase Inhibitor, in Sequential and Simultaneous Combinations with Daunorubicin and Cytarabine (DA) Induction and High-Dose Cytarabine Consolidation in Newly Diagnosed Patients with AML.

Richard M. Stone, Thomas Fischer, Ronald Paquette, Gary Schiller, Charles A. Schiffer, Gerhard Ehninger, Jorge Cortes, Hagop Kantarjian, Daniel A. DeAngelo, Richard Yu, Lei Zhang, Pamela S. Cohen, Yanfeng Wang, Penny Phillips, Francis Giles
Journal: Blood
Blood (2005) 106 (11): 404.
https://doi.org/10.1182/blood.V106.11.404.404
Published: 2005